DISPROPORTIONALITY ANALYSIS FOR PHARMACOVIGILANCE OF MEDICAL DEVICE RELATED ADVERSE EVENTS REPORTED TO THE FDA

被引：0
|
作者：
Duggirala, H. J. [1 ]
Herz, N. D. [1 ]
Canos, D. A. [1 ]
Sullivan, R. [1 ]
Schaaf, Richard [1 ]
Pinnow, E. [1 ]
Marinac-Dabic, D. [1 ]
机构：
[1] Ctr Devices & Radiol Hlth Food & Drug Adm, Silver Spring, MD 20993 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2011年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [41] A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database
    Li, Jie
    Xie, Jun
    Han, Yi
    Zhang, Wei
    Wang, Yilei
    Jiang, Zhitao
    ENDOCRINE JOURNAL, 2025, 72 (03) : 273 - 283
  • [42] Immune-related adverse events associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system
    Chen, Chen
    Wu, Bin
    Zhang, ChenYu
    Xu, Ting
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [43] Bleeding related adverse events associated with antiviral treatment in influenza patients: A disproportionality analysis using FDA adverse event reporting system (FAERS)
    Sarker, Jyotirmoy
    Carkovic, Emir
    Lee, Todd A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 486 - 487
  • [44] Comparison of pharmacovigilance algorithms in reported voriconazole adverse events
    Eiden, Celine
    Grand, Anais
    Peyriere, Helene
    Hillaire-Buys, Dominique
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 67 - 67
  • [45] A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen
    Du, Yikuan
    Guo, Zhuoming
    Xu, Bijun
    Yang, Yujia
    Hu, Mianda
    Hu, Yanghui
    Yang, Yurong
    Zhang, Mengting
    Wang, Zhenjie
    Guo, Xiaochun
    Huang, Yixing
    Zhu, Jinfeng
    Zhang, Weichui
    Yang, Chun
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 201 - 211
  • [46] Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
    Li, Yun
    Li, Hang
    Xiang, Zhongyuan
    HELIYON, 2024, 10 (06)
  • [47] Disproportionality Analysis of Cardiac Arrhythmia Events in the FDA Adverse Event Reporting System for Buprenorphine Patch
    Sessler, Nelson E.
    Walker, Ekaterina
    Coplan, Paul M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 467 - 467
  • [48] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
  • [49] Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
    Pan, Xianglin
    Xiao, Xiangtian
    Ding, Yiling
    Shu, Yamin
    Zhang, Wenting
    Huang, Liu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] A comprehensive analysis of MRI-related Cochlear implant adverse events reported by FDA's manufacturer and user facility device experience database
    Lin, Amy
    Menta, Arjun K.
    Ahmad, Syed Ameen
    Zhang, Aileen
    Perdomo, Dianela
    Reddy, Ashwin
    Ward, Bryan K.
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2025, 10 (01):
12345